TAF15 and Transportin 1 in Intranuclear Inclusions of Neuronal Intranuclear Inclusion Disease

Affiliations

¹ Department of Neuropathology, Biomedical Research Center, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
² Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
³ Institute for Medical Science of Aging, Aichi Medical University, Nagakute, Japan.
⁴ Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
⁵ Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.
⁶ Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.
⁷ Reta Lila Weston Institute of Neurological Studies, UCL Queen Square Institute of Neurology, London, UK.

Yasuo Miki et al. Neuropathol Appl Neurobiol. 2025 Jun.

. 2025 Jun;51(3):e70021.

doi: 10.1111/nan.70021.

¹ Department of Neuropathology, Biomedical Research Center, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
² Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
³ Institute for Medical Science of Aging, Aichi Medical University, Nagakute, Japan.
⁴ Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
⁵ Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.
⁶ Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.
⁷ Reta Lila Weston Institute of Neurological Studies, UCL Queen Square Institute of Neurology, London, UK.

No abstract available

Keywords: FTLD‐FUS; TAF15; intranuclear inclusion; neuronal intranuclear inclusion disease; transportin 1.

References

1. M. Neumann, E. Bentmann, D. Dormann, et al., “FET Proteins TAF15 and EWS Are Selective Markers That Distinguish FTLD With FUS Pathology From Amyotrophic Lateral Sclerosis With FUS Mutations,” Brain 134 (2011): 2595–2609.
1. J. Brelstaff, T. Lashley, J. L. Holton, et al., “Transportin1: A Marker of FTLD‐FUS,” Acta Neuropathologica 122 (2011): 591–600.
1. S. Tetter, D. Arseni, A. G. Murzin, et al., “TAF15 Amyloid Filaments in Frontotemporal Lobar Degeneration,” Nature 625 (2024): 345–351.
1. J. Sone, K. Mori, T. Inagaki, et al., “Clinicopathological Features of Adult‐Onset Neuronal Intranuclear Inclusion Disease,” Brain 139 (2016): 3170–3186.
1. H. Ishiura, S. Shibata, J. Yoshimura, et al., “Noncoding CGG Repeat Expansions in Neuronal Intranuclear Inclusion Disease, Oculopharyngodistal Myopathy and an Overlapping Disease,” Nature Genetics 51 (2019): 1222–1232.